Eaton Corporation plc vs Illumina, Inc. — how do they compare? Eaton Corporation plc trades at $427.4 (market cap $164.88B), while Illumina, Inc. trades at $268.9 (market cap $39.95B). The key difference: Eaton Corporation plc is far larger — about 4.1× Illumina, Inc.'s market cap, and Eaton Corporation plc pays a 1.04% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Eaton Corporation plc for 31 Days and Illumina, Inc. for 83 Days on average.
| ETN | ILMN | |
|---|---|---|
Market Cap | $164.88B | $39.95B |
Volume | 2,535,086 | 3,169,503 |
Sector | Industrials | Health |
52-Week High | $459.96 | $293.69 |
52-Week Low | $315.82 | $91.00 |
Typical Hold Time | 31 Days | 83 Days |
Enterprise Value | $185.51B | $41.31B |
Dividend Yield | 1.04% | — |
Signals from Pluang's Aura AI — not financial advice
Eaton Corporation (ETN) trades at $431.33, down 3.09% today but maintains strong analyst support with 70% buy ratings. The company shows consistent earnings beats and robust profitability with 12.75% net margins. Technical indicators suggest a bullish trend with support at $426 and resistance at $434. Recent acquisitions in data center and utility markets position ETN for durable growth in key infrastructure sectors.
Outlook remains positive with a $502.38 consensus price target representing 16% upside. Key opportunities include data center demand and grid modernization, while risks involve execution of recent acquisitions and potential market volatility. The company's strong backlog and strategic positioning in high-growth infrastructure markets support continued investor confidence.
Illumina (ILMN) trades at $267.76, down 2.11% today but remains near recent highs after a strong 94.9% YTD rally. The stock shows bullish technical momentum with recent earnings beats and improved profitability, with net income turning positive to $850 million in 2025 after previous losses. S&P 500 inclusion in September 2026 and growing AI integration in genomics provide positive catalysts, though valuation metrics remain elevated with a P/E of 49.36.
Outlook remains positive with analyst consensus favoring Buy ratings (54%) and a $241 price target, though current price exceeds consensus. Key opportunities include sequencing growth and AI adoption, while risks include China headwinds, margin pressure, and high valuation multiples requiring sustained execution to justify premium pricing.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Eaton is a global power management company providing energy-efficient solutions for electrical, aerospace, and industrial sectors. It focuses on improving sustainability through intelligent power technology.
Read more on ETN →Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →